Related references
Note: Only part of the references are listed.A Decreased Response to Resistin in Mononuclear Leukocytes Contributes to Oxidative Stress in Nonalcoholic Fatty Liver Disease
Cecilia C. Garcia et al.
DIGESTIVE DISEASES AND SCIENCES (2022)
Angiopoietin-like 8 (ANGPTL8) as a potential predictor of NAFLD in paediatric patients with Prader-Willi Syndrome
C. Mele et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2021)
Angiopoietin-like 8 Improves Insulin Resistance and Attenuates Adipose Tissue Inflammation in Diet-Induced Obese Mice
Deng Luo et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2020)
Increased Circulating Angiopoietin-Like Protein 8 Levels Are Associated with Thoracic Aortic Dissection and Higher Inflammatory Conditions
Yunyun Yang et al.
CARDIOVASCULAR DRUGS AND THERAPY (2020)
Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2020
DIABETES CARE (2020)
Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020
DIABETES CARE (2020)
Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity
Ilaria Barchetta et al.
LIVER INTERNATIONAL (2020)
Circulating ANGPTL8 Is Associated with the Presence of Metabolic Syndrome and Insulin Resistance in Polycystic Ovary Syndrome Young Women
Danlan Pu et al.
MEDIATORS OF INFLAMMATION (2019)
hs-CRP Is Associated With Incident Diabetic Nephropathy: Findings From the Jackson Heart Study
Satyesh K. Sinha et al.
DIABETES CARE (2019)
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
Pouya Saeedi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Resistin as a predictor of cardiovascular hospital admissions and renal deterioration in diabetic patients with chronic kidney disease
Bruno Bonito et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2019)
The potential role of angiopoietin-like protein-8 in type 2 diabetes mellitus: a possibility for predictive diagnosis and targeted preventive measures?
Yasmine Amr Issa et al.
EPMA JOURNAL (2019)
Non-alcoholic fatty liver disease - A global public health perspective
Zobair M. Younossi
JOURNAL OF HEPATOLOGY (2019)
ANGPTL8: An important Regulator in Metabolic Disorders
Mengdie Luo et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Resistin levels in non-alcoholic fatty liver disease pathogenesis
Carmela Colica et al.
JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE (2018)
The role of the complement system in diabetic nephropathy
Allan Flyvbjerg
NATURE REVIEWS NEPHROLOGY (2017)
EXPRESSION OF RESISTIN IN THE LIVER OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
Piotr Gierej et al.
POLISH JOURNAL OF PATHOLOGY (2017)
Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function
Chang-Chiang Chen et al.
CARDIOVASCULAR DIABETOLOGY (2016)
ANGPTL8/betatrophin alleviates insulin resistance via the Akt-GSK3β or Akt-FoxO1 pathway in HepG2 cells
Xing Rong Guo et al.
EXPERIMENTAL CELL RESEARCH (2016)
Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014
Maryam Afkarian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Increased ANGPTL3, 4 and ANGPTL8/betatrophin expression levels in obesity and T2D
Mohamed Abu-Farha et al.
LIPIDS IN HEALTH AND DISEASE (2016)
Non-alcoholic fatty liver disease and diabetes
Jonathan M. Hazlehurst et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Increased circulating resistin is associated with insulin resistance, oxidative stress and platelet activation in type 2 diabetes mellitus
Francesca Santilli et al.
THROMBOSIS AND HAEMOSTASIS (2016)
C-Reactive Protein Promotes Diabetic Kidney Disease in db/db Mice via the CD32b-Smad3-mTOR signaling Pathway
Yong-Ke You et al.
SCIENTIFIC REPORTS (2016)
Resolving Discrepant Findings on ANGPTL8 in β-Cell Proliferation: A Collaborative Approach to Resolving the Betatrophin Controversy
Aaron R. Cox et al.
PLOS ONE (2016)
Association between betatrophin/ANGPTL8 and non-alcoholic fatty liver disease: animal and human studies
Yong-ho Lee et al.
SCIENTIFIC REPORTS (2016)
Low-molecular-weight polyphenols protect kidney damage through suppressing NF-κB and modulating mitochondrial biogenesis in diabetic db/db mice
Hung-Wen Liu et al.
FOOD & FUNCTION (2016)
Circulating Betatrophin Levels Are Increased in Patients With Type 2 Diabetes and Associated With Insulin Resistance
Xi Chen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Higher plasma betatrophin/ANGPTL8 level in Type 2 Diabetes subjects does not correlate with blood glucose or insulin resistance
Mohamed Abu-Farha et al.
SCIENTIFIC REPORTS (2015)
Non-Alcoholic Fatty Liver Disease Is a Risk Factor for the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus
Guoyu Jia et al.
PLOS ONE (2015)
Adipsin Is an Adipokine that Improves β Cell Function in Diabetes
James C. Lo et al.
CELL (2014)
Increased Circulating Levels of Betatrophin in Newly Diagnosed Type 2 Diabetic Patients
Hao Hu et al.
DIABETES CARE (2014)
Circulating Betatrophin Concentrations Are Decreased in Human Obesity and Type 2 Diabetes
Javier Gomez-Ambrosi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Emerging roles of Lipasin as a critical lipid regulator
Ren Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Lipasin, thermoregulated in brown fat, is a novel but atypical member of the angiopoietin-like protein family
Zhiyao Fu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2013)
Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism
Gang Ren et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Resistin: functional roles and therapeutic considerations for cardiovascular disease
Md S. Jamaluddin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Juan F. Navarro-Gonzalez et al.
NATURE REVIEWS NEPHROLOGY (2011)
Correlation of plasma resistin with obesity and insulin resistance in type 2 diabetic patients
M. Y. Gharibeh et al.
DIABETES & METABOLISM (2010)
The global burden of diabetes and its complications: an emerging pandemic
Susan van Dieren et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2010)
Circulating resistin is increased with decreasing renal function in a general Japanese population: the Hisayama Study
Ryoichi Kawamura et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
The role of resistin as a regulator of inflammation: Implications for various human pathologies
Maria Filkova et al.
CLINICAL IMMUNOLOGY (2009)
Serum resistin is associated with the severity of microangiopathies in type 2 diabetes
Haruhiko Osawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance
J Axelsson et al.
KIDNEY INTERNATIONAL (2006)
Human resistin stimulates the pro-inflammatory cytokines TNF-α and IL-12 in macrophages by NF-κB-dependent pathway
N Silswal et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Resistin, an adipokine with potent proinflammatory properties
M Bokarewa et al.
JOURNAL OF IMMUNOLOGY (2005)
Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance
M Vedovato et al.
DIABETOLOGIA (2004)
Comparative studies of resistin expression and phylogenomics in human and mouse
RZ Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
A family of tissue-specific resistin-like molecules
CM Steppan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
